Pro Share Advisors LLC Humacyte, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 31,493 shares of HUMA stock, worth $49,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,493

Previous 25,387 24.05%

Holding current value

$49,129

Previous $43,000 51.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$1.15 - $2.77 $7,021 - $16,913	6,106 Added 24.05%	31,493 $65,000
Q1 2025 May 08, 2025	SELL	$1.71 - $5.18 $9,345 - $28,308	-5,465 Reduced 17.71%	25,387 $43,000
Q4 2024 Feb 13, 2025	BUY	$3.46 - $5.81 $24,870 - $41,762	7,188 Added 30.38%	30,852 $155,000
Q3 2024 Nov 13, 2024	BUY	$5.11 - $9.46 $41,442 - $76,720	8,110 Added 52.14%	23,664 $128,000
Q2 2024 Aug 13, 2024	SELL	$2.87 - $9.1 $7,771 - $24,642	-2,708 Reduced 14.83%	15,554 $74,000
Q1 2024 May 08, 2024	BUY	$2.57 - $4.84 $3,878 - $7,303	1,509 Added 9.01%	18,262 $56,000
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $4,051 - $6,352	2,036 Added 13.83%	16,753 $47,000
Q3 2023 Nov 13, 2023	BUY	$2.75 - $4.48 $184 - $300	67 Added 0.46%	14,717 $43,000
Q2 2023 Aug 10, 2023	BUY	$2.86 - $4.97 $1,664 - $2,892	582 Added 4.14%	14,650 $41,000
Q1 2023 May 11, 2023	SELL	$2.11 - $3.25 $4,272 - $6,581	-2,025 Reduced 12.58%	14,068 $43,000
Q4 2022 Feb 02, 2023	BUY	$2.02 - $3.62 $11,075 - $19,848	5,483 Added 51.68%	16,093 $33,000
Q3 2022 Nov 04, 2022	BUY	$1.22 - $5.14 $739 - $3,114	606 Added 6.06%	10,610 $34,000
Q2 2022 Aug 01, 2022	SELL	$3.21 - $7.86 $2,105 - $5,156	-656 Reduced 6.15%	10,004 $32,000
Q1 2022 May 10, 2022	SELL	$4.65 - $7.4 $17,883 - $28,460	-3,846 Reduced 26.51%	10,660 $75,000
Q4 2021 Feb 08, 2022	BUY	$7.25 - $11.6 $105,168 - $168,269	14,506 New	14,506 $105,000

Others Institutions Holding HUMA

# of Institutions

169

Shares Held

54.4M

Call Options Held

1.1M

Put Options Held

808K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $161M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Humacyte, Inc. Transaction History